7,8,9,12,13,14,20,28,29,30,33,34,35-Tridecahydroxy-3,18,21,24,39-pentaoxaheptacyclo[20.17.0.02,19.05,10.011,16.026,31.032,37]nonatriaconta-5,7,9,11,13,15,26,28,30,32,34,36-dodecaene-4,17,25,38-tetrone | 113866-64-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 单宁
• 英文名称: 7,8,9,12,13,14,20,28,29,30,33,34,35-Tridecahydroxy-3,18,21,24,39-pentaoxaheptacyclo[20.17.0.02,19.05,10.011,16.026,31.032,37]nonatriaconta-5,7,9,11,13,15,26,28,30,32,34,36-dodecaene-4,17,25,38-tetrone
• CAS: 113866-64-1
• 化学式: C₃₄H₂₄O₂₂
• 分子量: 784.5
• InChiKey: IYMHVUYNBVWXKH-UHFFFAOYSA-N

物化性质

• 沸点：
  1578.0±65.0 °C(Predicted)
• 密度：
  1.919±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  56
• 可旋转键数：
  0
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  377
• 氢给体数：
  13
• 氢受体数：
  22

文献信息

• FEIJOA FRUIT EXTRACT
  申请人：CALLAGHAN INNOVATION RESEARCH LIMITED

  公开号：US20150157678A1

  公开（公告）日：2015-06-11

  The invention relates to a feijoa fruit extract. In particular the invention relates to therapeutic uses of a feijoa fruit extract, processes for preparing the extract, and compositions comprising the extract. The feijoa fruit extract of the invention can be used in the treatment and prevention of rheumatoid arthritis and Type-2 diabetes.
• COMPOSITION FOR IMPROVING INTESTINAL BARRIER FUNCTION
  申请人：SUNTORY HOLDINGS LIMITED

  公开号：US20200315998A1

  公开（公告）日：2020-10-08

  An object of the present invention is to provide: a composition for improving intestinal barrier function capable of improving intestinal barrier function; and an agent for enhancing the intestinal barrier function improvement action of gallic acid. The present invention relates to a composition for improving intestinal barrier function, containing: gallic acid as an active ingredient.
• [EN] FEIJOA FRUIT EXTRACT<br/>[FR] EXTRAIT DE FRUIT DE FEIJOA
  申请人：CALLAGHAN INNOVATION RES LTD

  公开号：WO2013186680A1

  公开（公告）日：2013-12-19

  The invention relates to a feijoa fruit extract. In particular the invention relates to therapeutic uses of a feijoa fruit extract, processes for preparing the extract, and compositions comprising the extract. The feijoa fruit extract of the invention can be used in the treatment and prevention of rheumatoid arthritis and Type-2 diabetes.